Bioasis Technologies Stock Current Liabilities
| BIOAF Stock | USD 0.0002 0.00 0.00% |
biOasis Technologies fundamentals help investors to digest information that contributes to BiOasis Technologies' financial success or failures. It also enables traders to predict the movement of BiOasis Pink Sheet. The fundamental analysis module provides a way to measure BiOasis Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BiOasis Technologies pink sheet.
BiOasis |
biOasis Technologies Company Current Liabilities Analysis
BiOasis Technologies' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current BiOasis Technologies Current Liabilities | 437 K |
Most of BiOasis Technologies' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, biOasis Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, biOasis Technologies has a Current Liabilities of 437 K. This is 99.98% lower than that of the Biotechnology sector and 99.92% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.99% higher than that of the company.
BiOasis Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BiOasis Technologies' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BiOasis Technologies could also be used in its relative valuation, which is a method of valuing BiOasis Technologies by comparing valuation metrics of similar companies.BiOasis Technologies is currently under evaluation in current liabilities category among its peers.
BiOasis Fundamentals
| Return On Asset | -0.81 | |||
| Operating Margin | (11.41) % | |||
| Current Valuation | 6 M | |||
| Shares Outstanding | 79.41 M | |||
| Shares Owned By Insiders | 2.05 % | |||
| Price To Earning | 13.82 X | |||
| Price To Book | 53.47 X | |||
| Price To Sales | 26.52 X | |||
| Revenue | 37.73 K | |||
| Gross Profit | (1.15 M) | |||
| EBITDA | (3.54 M) | |||
| Net Income | (2.96 M) | |||
| Cash And Equivalents | 764.97 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 401.76 K | |||
| Debt To Equity | 0.31 % | |||
| Current Ratio | 0.38 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (3.64 M) | |||
| Earnings Per Share | (0.03) X | |||
| Target Price | 0.58 | |||
| Number Of Employees | 23 | |||
| Beta | 0.39 | |||
| Market Capitalization | 2.13 M | |||
| Total Asset | 2.27 M | |||
| Retained Earnings | (18.69 M) | |||
| Working Capital | 437 K | |||
| Current Asset | 874 K | |||
| Current Liabilities | 437 K | |||
| Z Score | -11.5 | |||
| Net Asset | 2.27 M |
About BiOasis Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze biOasis Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BiOasis Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of biOasis Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Other Information on Investing in BiOasis Pink Sheet
BiOasis Technologies financial ratios help investors to determine whether BiOasis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BiOasis with respect to the benefits of owning BiOasis Technologies security.